Pancreatic Ductal Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Pancreatic Ductal Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-10-20Clinical Trial Update: A Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 clinical trial update describing safety, tolerability, and imaging with [68Ga]Ga-DPI-4452 and safety, tolerability, and efficacy…
-
CLINICAL_TRIALS research · 2025-10-14Clinical Trial Update: Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor Malignancies [Phase 1]
A Phase 1 study of JANX008 in advanced or metastatic solid tumors is currently recruiting, evaluating multiple indications including Non-Sma…
-
CLINICAL_TRIALS research · 2025-10-01Clinical Trial Update: ProAgio in Pancreatic Ductal Adenocarcinoma (PDAC) [Phase 1]
Phase 1 clinical trial update for ProAgio in pancreatic ductal adenocarcinoma, currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-30Clinical Trial Update: A Single-Arm, Open-Label, Multicenter Phase I/II Clinical Study of GFH276 in Patients With RAS-Mutant Advanced Solid Tumors [Phase 1, Phase 2]
This clinical trial update describes a single-arm, open-label Phase I/II study of GFH276 in patients with RAS-mutant advanced solid tumors, …
-
CLINICAL_TRIALS research · 2025-09-23Clinical Trial Update: Utility of ctDNA in Early Switch of First-line mFOLFIRINOX in Metastatic Pancreatic Ductal Adenocarcinoma [Phase 2]
A Phase 2 clinical trial evaluating whether circulating tumor DNA can guide an early switch from first-line mFOLFIRINOX in metastatic pancre…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: Prospectively Defining Metastatic Pancreatic Ductal Adenocarcinoma Subtypes by Comprehensive Genomic Analysis
A clinical trial designed to prospectively define subtypes of metastatic pancreatic ductal adenocarcinoma using comprehensive genomic analys…
-
CLINICAL_TRIALS research · 2025-09-18Clinical Trial Update: UCSF PANC Cyst Registry
Update on the UCSF PANC Cyst Registry clinical trial, which is currently recruiting and investigating pancreatic cysts and pancreatic neopla…
-
CLINICAL_TRIALS research · 2025-09-10Clinical Trial Update: Endoscopic Ultrasound Radiofrequency Ablation and Immunotherapy Pembrolizumab for Locally Advanced Unresectable and Metastatic Pancreatic Duct Adenocarcinoma [Phase 2]
Phase 2 study evaluating endoscopic ultrasound-guided radiofrequency ablation combined with pembrolizumab for locally advanced unresectable …
-
CLINICAL_TRIALS research · 2025-09-05Clinical Trial Update: Oncological Safety of Spleen Preservation in Left Pancreatectomy for Pancreatic Ductal Adenocarcinoma (SPLENDID)
This clinical trial evaluates the oncological safety of spleen preservation during left pancreatectomy for resectable pancreatic ductal aden…
-
CLINICAL_TRIALS research · 2025-09-04Clinical Trial Update: Imaging Study of 18F-FAC PET Scans to Assess Standard Treatment in People With Pancreatic Cancer [EARLY_Phase 1]
A phase 1 imaging trial using 18F-FAC PET scans to assess standard treatment in people with pancreatic cancer, currently active but not recr…
-
CLINICAL_TRIALS research · 2025-09-03Clinical Trial Update: First-line Regimen With QL1706 Plus Chemo ± Bev in PDAC Patients [Phase 2]
This entry describes an ongoing Phase 2 trial evaluating first-line therapy with QL1706 plus chemotherapy with or without bevacizumab in pan…
-
CLINICAL_TRIALS research · 2025-08-29Clinical Trial Update: Mesopancreatic Excision for Pancreatic Duct Adenocarcinoma. [NA]
A clinical trial update on mesopancreatic excision for pancreatic ductal adenocarcinoma, which is currently recruiting.
-
CLINICAL_TRIALS research · 2025-08-28Clinical Trial Update: Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors [Phase 1]
A Phase 1 clinical trial evaluating the KRAS G12D-targeting agent RMC-9805 is currently recruiting for multiple solid tumor indications incl…
-
CLINICAL_TRIALS research · 2025-08-28Clinical Trial Update: Master Protocol of TCR-modified T Cell Therapy Targeting HLA-restricted KRAS Antigen Administered in Adult Patients With Metastatic or Locally Advanced PDAC [Phase 1, Phase 2]
This clinical trial update describes a master protocol for TCR-modified T cell therapy targeting an HLA-restricted KRAS antigen, studied in …
-
CLINICAL_TRIALS research · 2025-08-22Clinical Trial Update: A Vaccine (Ad5.F35-hGCC-PADRE) for the Treatment of Gastrointestinal Adenocarcinoma [Phase 2]
Phase 2 clinical trial update on the Ad5.F35-hGCC-PADRE cancer vaccine for pancreatic, colorectal, gastric, and esophageal adenocarcinomas; …
-
CLINICAL_TRIALS research · 2025-08-14Clinical Trial Update: The Miami "EMPIRE" Trial - Eradication of Metastatic Pancreatic Cancer With Immuno-Radiation [Phase 2]
The Miami 'EMPIRE' trial is a Phase 2 study evaluating immuno-radiation for eradication of metastatic pancreatic ductal adenocarcinoma. The …
-
CLINICAL_TRIALS research · 2025-08-12Clinical Trial Update: Artificial Intelligence-powered Low-Dose Computed Tomography for Screening of Pancreatic Cancer
A clinical trial update describes an artificial intelligence–driven, low-dose CT screening method being studied for pancreatic cancer and re…
-
CLINICAL_TRIALS research · 2025-08-07Clinical Trial Update: A Study of GnP RegimenCombined With Serplulimab and Stereotactic Body Radiation Therapy as First-line Treatment for Locally Advanced Pancreatic Cancer [Phase 2]
Phase 2 clinical trial evaluating gemcitabine/nab-paclitaxel (GnP) plus serplulimab and stereotactic body radiation therapy as first-line tr…
-
CLINICAL_TRIALS research · 2025-08-01Clinical Trial Update: Clinical Performance of Medical Device Software "Lipidica 1.0" for Processing Data Generated by Lipidomic Analysis in Pancreatic Cancer Screening [NA]
An update on the clinical performance study of Lipidica 1.0, a medical device software that analyzes lipidomic data for pancreatic cancer sc…
-
CLINICAL_TRIALS research · 2025-07-30Clinical Trial Update: Phase I Study of Autologous CD8+ and CD4+ Engineered T Cell Receptor T Cells in Subjects With Advanced or Metastatic Solid Tumor [Phase 1, Phase 2]
Update on a Phase I/II autologous engineered TCR T-cell therapy trial for advanced pancreatic ductal adenocarcinoma, non-small cell lung can…
-
CLINICAL_TRIALS research · 2025-07-28Clinical Trial Update: Anti-CD38 Antibody With KRAS Vaccine and Anti-PD-1 Antibody in Subjects With Pancreatic Ductal Adenocarcinoma and Refractory Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial tests an anti-CD38 antibody with a KRAS vaccine and an anti-PD-1 antibody in pancreatic ductal adenocarcinoma and r…
-
CLINICAL_TRIALS research · 2025-07-25Clinical Trial Update: OSE2101+FOLFIRI, or FOLFIRI Maintenance After FOLFIRINOX-based Induction Therapy in Advanced or Metastatic PDAC [Phase 2]
This entry describes a Phase 2 trial evaluating OSE2101 with FOLFIRI, or FOLFIRI maintenance after FOLFIRINOX induction, in advanced or meta…
-
CLINICAL_TRIALS research · 2025-07-18Clinical Trial Update: Neoadjuvant Folfirinox Combined With Pembrolizumab Followed by Surgery for Patients With Resectable Pancreatic Cancer [Phase 2]
Phase 2 clinical trial evaluating neoadjuvant FOLFIRINOX plus pembrolizumab followed by surgery for resectable pancreatic ductal adenocarcin…
-
CLINICAL_TRIALS research · 2025-07-10Clinical Trial Update: Liquid Biopsy and Pancreas Cancer: Detection of AXL(+) CTCs (CTC-AXL-PANC) [NA]
This clinical trial update describes a study evaluating liquid biopsy to detect AXL-positive circulating tumor cells in pancreatic ductal ad…
-
CLINICAL_TRIALS research · 2025-07-10Clinical Trial Update: French Assessment of MRD by Liquid Biopsies in PDAC Patients (FRENCH.MRD.PDAC)
A French study (FRENCH.MRD.PDAC) is evaluating minimal residual disease by liquid biopsies, including ctDNA, in patients with resectable pan…